Enhancement by Diuretics of the Antihypertensive Action of Long-Term Angiotensin Converting Enzyme Blockade
- 1 January 1980
- journal article
- research article
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 2 (3-4) , 639-657
- https://doi.org/10.3109/10641968009037134
Abstract
Thirty-nine patients with various types of hypertension were treated by chronic blockade of the angiotensin converting enzyme, i.e. by twice daily administration of captopril, 50 to 200 mg p.o. The blood pressure reduction observed 1 hour following administration of the inhibitor was directly related to the baseline plasma renin activity (r=− 0.67, p < 0.001). Whenever blockade of the renin system alone did not lower blood pressure to normal levels additional sodium subtraction brought it under control. With the renin system neutralized, blood pressure becomes exquisitely sensitive to changes in sodium balance. Diuretics seem to preserve optimal natriuretic efficacy despite blood pressure reduction, probably because aldosterone levels are reduced and renal blood flow increases. Blockade of the renin system together with individually tailored salt subtraction provides an attractive new approach to long-term treatment of clinical hypertension.Keywords
This publication has 20 references indexed in Scilit:
- Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.Hypertension, 1979
- Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive PatientsAnnals of Internal Medicine, 1979
- Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension, 1978
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- INNAPPROPRIATE RENIN SECRETION UNMASKED BY CAPTOPRIL (SQ 14 225) IN HYPERTENSION OF CHRONIC RENAL FAILUREThe Lancet, 1978
- A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MANThe Lancet, 1977
- Mechanisms regulating renin releasePhysiological Reviews, 1976
- Angiotensin I converting enzyme.Circulation Research, 1975
- An Angiotensin Converting-Enzyme Inhibitor to Identify and Treat Vasoconstrictor and Volume Factors in Hypertensive PatientsNew England Journal of Medicine, 1974
- Angiotensin II Vascular Receptors: Their Avidity in Relationship to Sodium Balance, the Autonomic Nervous System, and HypertensionJournal of Clinical Investigation, 1972